טוען...
MATERNAL PLASMA VISFATIN IN PRETERM LABOR
OBJECTIVE: Visfatin, a novel adipokine with diabetogenic and immunomodulatory properties, has been implicated in the pathophysiology of insulin resistance, as well as in various acute and chronic inflammatory disorders. We have previously reported that amniotic fluid concentrations of visfatin are h...
שמור ב:
| הוצא לאור ב: | J Matern Fetal Neonatal Med |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2009
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6656365/ https://ncbi.nlm.nih.gov/pubmed/19572235 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14767050902994788 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|